3[22]Mistry P,Stewart AJ,Dangerfield W,et al.In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator,XR9576[J].Cancer Res,2001,61(2):749
4[23]Shepard RL,Cao J,Starling JJ,et al.Modulation of P-glycoprotein but not MRP1-or BCRP-mediated drug resistance by LY335979[J].Int J Cancer,2003,103(1):121
5[24]van Zuylen L,Sparreboom A,van der Gaast A,et al.Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933[J].Eur J Cancer,2002,38(8):1090
7[26]Barraud de Lagerie S,Comets E,Gautrand C,et al.Cerebral uptake of mefloquine enantiomers with and without the P-gp inhibitor elacridar (GF1210918) in mice[J].Br J Pharmacol,2004,141(7):1214
8[27]Kakumoto M,Sakaeda T,Takara K,et al.Effects of carvedilol on MDR1-mediated multidrug resistance:comparison with verapamil[J].Cancer Sci,2003,94(1):81
9[28]Jonsson O,Behnam-Motlagh P,Persson M,et al.Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity[J].Biochem Pharmacol,1999,58(11):1801
10[29]Sharma R,Awasthi YC,Yang Y,et al.Energy dependent transport of xenobiotics and its relevance to multidrug resistance[J].Curr Cancer Drug Targets,2003,3(2):89
